Ambrx Biopharma Inc ADR (AMAM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AMAM | CLDX | AGIO | ||
| Company | Ambrx Biopharma Inc ADR | Celldex Therapeutics | Agios Pharmaceuticals | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 27.99 | 26.57 | 29.06 | ||
| High | 28.00 | 26.58 | 29.06 | ||
| Low | 27.98 | 26.05 | 27.42 | ||
| Latest | 28.00 | 26.40 | 28.02 | ||
| Change | +0.02 | -0.43 | -1.15 | ||
| % Change | +0.07% | -1.60% | -3.94% | ||
| Volume | 1,439,600 | 356,200 | 1,705,600 | ||
| 20-Day Average Volume | 1,545,680 | 751,865 | 1,676,400 | ||
| Previous Close | 27.98 | 26.83 | 29.17 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 27.86 | 27.28 | 26.89 | ||
| 20-Day Raw Stochastic | 94.23% | 25.85% | 65.65% | ||
| 20-Day Relative Strength | 80.97 | 49.63 | 44.43 | ||
| Weighted Alpha | +89.90 | +10.14 | +15.58 | ||
| Today's Opinion | 100% Buy | 80% Buy | 72% Sell | ||
| Previous Opinion | 100% Buy | 80% Buy | 56% Sell | ||
| Last Month's Opinion | 100% Buy | 72% Buy | 24% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.21% since 02/28/24 | +4.39% since 12/18/25 | +13.30% since 12/18/25 | ||
| Low | 27.93 on 03/01/24 | 25.09 on 12/19/25 | 24.16 on 12/22/25 | ||
| High | 28.00 on 03/06/24 | 27.92 on 12/22/25 | 30.04 on 12/24/25 | ||
| 1-Month | |||||
| %Chg | +0.79% since 02/06/24 | -1.46% since 11/26/25 | -3.51% since 11/26/25 | ||
| Low | 27.51 on 02/20/24 | 24.97 on 12/18/25 | 24.16 on 12/22/25 | ||
| High | 28.03 on 02/26/24 | 30.50 on 12/08/25 | 30.04 on 12/24/25 | ||
| 3-Month | |||||
| %Chg | +132.75% since 12/06/23 | +0.99% since 09/26/25 | -28.02% since 09/26/25 | ||
| Low | 11.74 on 12/12/23 | 22.10 on 11/11/25 | 22.24 on 11/19/25 | ||
| High | 28.15 on 01/10/24 | 30.50 on 12/08/25 | 46.00 on 11/18/25 | ||
| 6-Month | |||||
| %Chg | +111.32% since 09/06/23 | +24.70% since 06/26/25 | -16.73% since 06/26/25 | ||
| Low | 6.55 on 10/23/23 | 19.52 on 06/30/25 | 22.24 on 11/19/25 | ||
| High | 28.15 on 01/10/24 | 30.50 on 12/08/25 | 46.00 on 11/18/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,768,200 | 1,782,826 | 1,701,019 | ||
| Shares Outstanding, K | 63,150 | 66,449 | 58,314 | ||
| Annual Sales | 7,400,000 | 7,020,000 | 36,500,000 | ||
| Annual Net Income | -78,000,000 | -157,860,000 | 673,730,000 | ||
| Last Quarter Sales | 1,120,000 | 730,000 | 12,880,000 | ||
| Last Quarter Net Income | -17,830,000 | -56,600,000 | -103,430,000 | ||
| 60-Month Beta | -1.92 | 1.13 | 0.87 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.05 on 08/09/23 | -1.01 on 11/10/25 | -1.78 on 10/30/25 | ||
| Latest Earnings Date | 04/04/24 | 02/26/26 | 02/12/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||